EX-99.3 5 ex-99d3.htm EX-99.3 petq_ex99.3

PETIQ, Inc.

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

 

On July 7, 2019, PetIQ, Inc. (the “Company”), through its subsidiary PetIQ, LLC completed the acquisition of all the outstanding stock of Sergeant’s Pet Care Products, Inc. (“Sergeant’s”), dba Perrigo Animal Health, including any assets related to Perrigo Company plc’s animal health business (“Sergeant’s acquisition”).  Sergeant’s is now an indirect wholly-owned subsidiary of the Company. 

 

The following unaudited pro forma condensed combined financial information presents the unaudited pro forma condensed combined balance sheet as of March 31, 2019, and unaudited pro forma condensed combined statements of operations for the year ended December 31, 2018, and the three-months ended March 31, 2019 based on the historical financial statements of the Company and Sergeant’s, after giving effect to the following transactions (the “Transactions”):  

 

·

Conformance of Sergeant’s accounting policies to the Company’s

·

Application of the acquisition method of accounting to the Sergeant’s acquisition

·

Transaction costs directly attributable to the Sergeant’s acquisition;

·

Estimated impact of the July 8, 2019 amendment to the Company’s existing revolving credit agreement that increased the size of the revolving facility to $110 million with an accordion feature allowing for an additional increase up to $125 million and extending the maturity date of the revolving facility to July 8, 2024; and

·

Estimated impact of the July 8, 2019 amended and restated term loan credit agreement (the A&R Term Loan Credit Agreement”) providing for a secured term loan facility of $220 million, maturing on July 8, 2025, which proceeds were used to refinance the existing term loan facility and fund the acquisition.

 

The unaudited pro forma condensed combined balance sheet gives effect to the Transactions as if they had occurred on March 31, 2019.  The unaudited pro forma condensed combined statements of operations for the year ended December 31, 2018  and the three-months ended March 31, 2019 gives effects to the Transactions as if they had been consummated on January 1, 2018. 

 

The unaudited pro forma condensed combined financial information has been prepared from (a) the audited consolidated financial statements of PetIQ, Inc. contained in its annual report on Form 10-K for the year ended December 31, 2018,  filed on March 12, 2019 and the unaudited consolidated financial statements of PetIQ, Inc. contained in its Quarterly Report on Form 10-Q for the three-months ended March 31, 2019, filed on May 5, 2019 and (b) the audited combined financial statements of Perrigo Company plc’s animal health business for the year ended December 31, 2018, included as exhibit 99.1 in this Form 8-K/A and the unaudited combined financial statements of Perrigo Company plc’s animal health business for the three-months ended March  30, 2019, included as exhibit 99.2 in this Form 8-K/A.  Historical results of Perrigo Company plc’s animal health business have been adjusted to reclassify certain amounts to conform with the Company’s presentation.

 

The unaudited pro forma condensed combined financial information is prepared in accordance with SEC Article 11 of Regulation S-X, using the assumptions set forth in the notes to the unaudited pro forma condensed combined financial information.  The unaudited pro forma condensed combined financial information has been prepared to reflect adjustments to our historical financial information that are (i)  directly attributable to the Transactions described above, (ii) factually supportable and, (iii) with respect to the Unaudited Pro Forma Condensed Combined Statement of Income (Loss), expected to have a continuing impact on our results.    

 

The unaudited pro forma condensed combined financial information is provided for informational purposes only and is not necessarily indicative of the operating results that would have occurred if the Transactions had been completed as of the dates set forth above, nor is it indicative of the future results of the Company.  The unaudited pro forma condensed financial information does not give effect to the potential impact of any anticipated synergies, operating efficiencies, or cost savings that may result from the Sergeant’s acquisition or any integration costs that do not have a continuing impact.  

 

The unaudited pro forma condensed combined financial information was prepared using the acquisition method of accounting in accordance with ASC 805, Business Combinations, with the Company considered the acquiring company.  Based on the acquisition method of accounting, the consideration paid for the Sergeant’s acquisition is allocated to its assets and liabilities based on their fair value as of the closing date of the acquisition,  July 7, 2019.   The Company has obtained preliminary third-party valuations of inventory, property plant and equipment, intangible assets, and certain other assets and liabilities.  The values of certain assets and liabilities are based on preliminary valuations, as allowed by

U.S. generally accepted accounting principles, and are subject to adjustment as additional information is obtained.  We cannot provide any assurances that such adjustments will not result in a material change to the accompanying unaudited pro forma condensed combined financial information and the combined company’s future results of operation and financial position.

 

The unaudited pro forma condensed combined financial information should be read in conjunction with the separate historical consolidated financial statements of the Company and combined financial statements of Perrigo Company plc’s animal health business.

Unaudited Pro Forma Condensed Combined Statements of Income (Loss)

For the three months ended:

Amounts in 000’s except for per share amounts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Historical

 

Pro Forma

 

 

March 31, 2019

 

March 30, 2019

 

 

 

 

 

 

 

 

 

 

 

As adjusted,

 

 

 

 

 

 

 

    

PetIQ

    

Sergeant's

 

Adjustments

    

Combined

Product sales

 

$

126,084

 

$

19,569

 

$

 —

 

$

145,653

Services revenue

 

 

22,352

 

 

 —

 

 

 —

 

 

22,352

Total net sales

 

 

148,436

 

 

19,569

 

 

 —

 

 

168,005

Cost of products sold

 

 

108,064

 

 

10,610

 

 

(1,363)

6(b)

 

117,311

Cost of services

 

 

15,642

 

 

 —

 

 

 —

 

 

15,642

Total cost of sales

 

 

123,706

 

 

10,610

 

 

(1,363)

 

 

132,953

Gross profit

 

 

24,730

 

 

8,959

 

 

1,363

 

 

35,052

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 —

General and administrative expenses

 

 

20,538

 

 

8,684

 

 

(483)

6(b) (c)

 

28,739

Contingent note revaluations gain

 

 

(680)

 

 

 —

 

 

 —

 

 

(680)

Operating income

 

 

4,872

 

 

275

 

 

1,846

 

 

6,993

Interest expense, net

 

 

(1,937)

 

 

 —

 

 

(3,096)

6(d)

 

(5,033)

Foreign currency loss, net

 

 

(122)

 

 

 —

 

 

 —

 

 

(122)

  Other income, net

 

 

13

 

 

 —

 

 

 

 

 

13

Total other expense, net

 

 

(2,046)

 

 

 —

 

 

(3,096)

 

 

(5,142)

Pretax net income (loss)

 

 

2,826

 

 

275

 

 

(1,250)

 

 

1,851

Income tax (expense) benefit

 

 

(500)

 

 

 —

 

 

285

6(e)

 

(215)

Net income (loss)

 

$

2,326

 

$

275

 

$

(965)

 

$

1,636

Net income (loss) attributable to non-controlling interest

 

 

715

 

 

 —

 

 

(220)

6(f)

 

495

Net income (loss) attributable to PetIQ, Inc. before nonrecurring charges or credits directly attributable to the transaction

 

 

1,611

 

 

275

 

 

(745)

 

 

1,141

Net income (loss) per share attributable to PetIQ, Inc. Class A common stock

 

 

 

 

 

 

 

 

 

 

 

 

-Basic

 

 

0.07

 

 

 —

 

 

 —

 

 

0.05

-Diluted

 

 

0.07

 

 

 —

 

 

 —

 

 

0.05

Weighted average shares of Class A common stock outstanding

 

 

 

 

 

 

 

 

 

 

 

 

-Basic

 

 

21,800

 

 

 —

 

 

 —

 

 

21,800

-Diluted

 

 

21,978

 

 

 —

 

 

 —

 

 

21,978

 

 

 

Unaudited Pro Forma Condensed Combined Statements of Income (Loss)

For the year ended December 31, 2018

Amounts in 000’s except for per share amounts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Historical

 

Pro Forma

 

 

 

 

 

As adjusted,

 

 

 

 

 

 

 

    

PetIQ

    

Sergeant's

 

Adjustments

    

Combined

 

 

 

 

 

 

 

 

 

 

 

 

 

Product sales

 

$

450,229

 

$

91,885

 

$

(1,821)

6(a)

$

540,293

Services revenue

 

 

78,385

 

 

 —

 

 

 —

 

 

78,385

Total net sales

 

 

528,614

 

 

91,885

 

 

(1,821)

 

 

618,678

Cost of products sold

 

 

383,501

 

 

65,399

 

 

(22,607)

6(a)(b)

 

 

Cost of services

 

 

61,825

 

 

 —

 

 

 —

 

 

61,825

Total cost of sales

 

 

445,326

 

 

65,399

 

 

(22,607)

 

 

488,118

Gross profit

 

 

83,288

 

 

26,486

 

 

20,786

 

 

130,560

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 —

General and administrative expenses

 

 

72,260

 

 

35,993

 

 

344

6(b)

 

108,597

Contingent note revaluations loss

 

 

3,280

 

 

 —

 

 

 —

 

 

3,280

   Impairment Charges

 

 

 —

 

 

172,451

 

 

 —

 

 

172,451

Operating income (loss)

 

 

7,748

 

 

(181,958)

 

 

20,442

 

 

(153,768)

Interest expense, net

 

 

(8,022)

 

 

 —

 

 

(12,379)

6(d)

 

(20,401)

Foreign currency loss, net

 

 

45

 

 

 —

 

 

 —

 

 

45

  Other (expense) income, net

 

 

(345)

 

 

250

 

 

 —

 

 

(95)

Total other expense, net

 

 

(8,322)

 

 

250

 

 

(12,379)

 

 

(20,451)

Pretax net (loss) income

 

 

(574)

 

 

(181,708)

 

 

8,063

 

 

(174,219)

Income tax benefit

 

 

661

 

 

13,569

 

 

5,113

6(e)

 

19,343

Net income (loss)

 

$

87

 

$

(168,139)

 

$

13,176

 

$

(154,876)

Net income (loss) attributable to non-controlling interest

 

 

869

 

 

 —

 

 

(59,579)

6(f)

 

(58,710)

Net (loss) income attributable to PetIQ, Inc.

 

 

(782)

 

 

(168,139)

 

 

72,756

 

 

(96,165)

Net income (loss) per share attributable to PetIQ, Inc. Class A common stock

 

 

 

 

 

 

 

 

 

 

 

 

-Basic

 

 

(0.05)

 

 

 —

 

 

 —

 

 

(5.59)

-Diluted

 

 

(0.05)

 

 

 —

 

 

 

 

 

(5.59)

Weighted Average shares of Class A common stock outstanding

 

 

 

 

 

 

 

 

 

 

 

 

-Basic

 

 

17,216

 

 

 —

 

 

 —

 

 

17,216

-Diluted

 

 

17,216

 

 

 —

 

 

 —

 

 

17,216

 

Unaudited Pro Forma Condensed Combined Balance Sheets

Amounts in 000’s except for per share amounts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Historical

 

Pro Forma

 

 

As of March 31, 2019

 

As of March 30, 2019

 

 

 

 

 

 

 

 

 

 

 

As adjusted,

 

 

 

 

 

 

 

    

PetIQ

    

Sergeant's

    

Adjustments

    

Combined

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

$

54,367

 

$

116

 

$

(25,027)

5(a)

$

29,456

Accounts receivable, net

 

 

65,466

 

 

14,731

 

 

 —

 

 

80,197

Inventories

 

 

112,539

 

 

16,511

 

 

4,205

5(b)

 

133,255

Prepaid expenses and other current assets

 

 

4,313

 

 

2,421

 

 

(338)

5(c)

 

6,396

Total current assets

 

 

236,685

 

 

33,779

 

 

(21,160)

 

 

249,304

Property and equipment, net

 

 

26,811

 

 

10,684

 

 

5,951

5(d)

 

43,446

Operating lease right of use assets

 

 

9,860

 

 

11,161

 

 

(341)

5(e)

 

20,680

Deferred tax assets

 

 

46,585

 

 

 —

 

 

 —

 

 

46,585

Other non current assets

 

 

2,667

 

 

12

 

 

650

5(a)

 

3,329

Intangible assets, net

 

 

87,366

 

 

36,922

 

 

(4,232)

5(f)

 

120,056

Goodwill

 

 

125,279

 

 

29,633

 

 

83,062

5(g)

 

237,974

Total non-current assets

 

 

298,568

 

 

88,412

 

 

85,090

 

 

472,070

Total assets

 

$

535,253

 

$

122,191

 

$

63,930

 

$

721,374

Liabilities and Equity

 

 

  

 

 

  

 

 

 

 

 

 

Accounts payable

 

$

71,023

 

$

8,088

 

$

 —

 

$

79,111

Accrued wages payable

 

 

4,158

 

 

747

 

 

 —

 

 

4,905

Accrued interest payable

 

 

607

 

 

 —

 

 

 —

 

 

607

Other accrued expenses

 

 

919

 

 

4,879

 

 

 —

 

 

5,798

Current portion of operating leases

 

 

2,862

 

 

1,481

 

 

394

5(e)

 

4,737

Current portion of long-term debt and capital leases

 

 

2,446

 

 

 —

 

 

1,450

5(h)

 

3,896

Total current liabilities

 

 

82,015

 

 

15,195

 

 

1,844

 

 

99,054

Operating Lease , less current installments

 

 

7,170

 

 

9,694

 

 

(750)

5(e)

 

16,114

Long-term debt, less current installments

 

 

115,274

 

 

 —

 

 

164,483

5(h)

 

279,757

Capital leases, less current installments

 

 

1,944

 

 

 —

 

 

 —

 

 

1,944

Other non-current liabilities

 

 

268

 

 

449

 

 

 —

 

 

717

Total non-current liabilities

 

 

124,656

 

 

10,143

 

 

163,733

 

 

298,532

Total liabilities 

 

 

206,671

 

 

25,338

 

 

165,577

 

 

397,586

Commitments and contingencies

 

 

  

 

 

  

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

 

 

 

 

 —

Additional paid-in capital

 

 

271,916

 

 

 —

 

 

 —

 

 

271,916

Net parent investment

 

 

 —

 

 

96,853

 

 

(96,853)

5(i)

 

 —

Class A common stock; par value $0.001 per share, 125,000 shares authorized, 22,157 shares issued and outstanding at March 31, 2019

 

 

22

 

 

 —

 

 

 —

 

 

22

Class B common stock, par value $0.001 per share, 100,000 shares authorized, 6,028 shares issued and outstanding at March 31, 2019

 

 

 6

 

 

 —

 

 

 —

 

 

 6

Accumulated deficit

 

 

(2,839)

 

 

 —

 

 

(4,794)

5(a)(j)

 

(7,633)

Accumulated other comprehensive loss

 

 

(941)

 

 

 —

 

 

 —

 

 

(941)

Total Equity

 

 

268,164

 

 

96,853

 

 

(101,647)

 

 

263,370

Non controlling interest

 

 

60,418

 

 

 —

 

 

 —

 

 

60,418

Total Equity

 

 

328,582

 

 

96,853

 

 

(101,647)

 

 

323,788

Total liabilities and equity

 

$

535,253

 

$

122,191

 

$

63,930

 

$

721,374

 

Notes to Unaudited Pro Forma Condensed Combined Financial Statements

Dollars in 000’s unless noted otherwise

 

1. Basis of Presentation

 

The unaudited pro forma condensed combined financial information and related notes are prepared in accordance with SEC Article 11 of Regulations S-X and present the historical financial information of the Company and Perrigo Company plc’s animal health business adjusted to give pro forma effect to events that are (i) directly attributable to the Transactions, (ii) factually supportable and (iii) with respect to the unaudited pro forma condensed combined statement of operations, expected to have a continuing impact on the combined results. 

 

The Sergeant’s acquisition will be accounted for under the acquisition method of accounting in accordance with ASC 805, Business Combinations.  Under the acquisition method of accounting, the purchase price will be allocated to the Sergeant’s assets acquired and liabilities assumed based upon their estimated fair values, using fair value concepts defined in ASC 820, Fair Value Measurements,  at the date of completion of the acquisition.  Any excess purchase price consideration over the preliminary estimate of the fair value of the identified assets acquired and liabilities assumed will be recorded to goodwill.  Significant judgment is required in determining the preliminary fair values of identified intangible assets, inventory, property, plant and equipment, and certain other assets and liabilities.  These preliminary valuations of assets acquired and liabilities assumed are determined using market, income, and cost approaches from the perspective of a market participant, which requires estimates and assumptions, including, but not limited to, estimating cash flows in addition to developing the appropriate market discount rates and obtaining market pricing for comparable assets.  The final valuation may materially change the allocation of the purchase price, which could materially affect fair values assigned to the assets acquired and liabilities assumed and could result in a material change to the unaudited pro forma condensed combined financial information. 

 

The unaudited pro forma condensed combined balance sheet gives effect to the Transactions, as if they had occurred on March 31, 2019.  The unaudited pro forma condensed combined statement of operations for the year ended December 31, 2018 and for the three-months ended March 31, 2019, gives effect to the Transactions as if they had occurred on January 1, 2018.  

 

The unaudited pro forma condensed combined financial statements are based on a preliminary purchase price allocation, provided for illustrative purposes only, and do not purport to represent what the Companies results of operations would have been had the Acquisition occurred on the dates indicated. They also may not be useful in predicting the future financial condition and results of operations of the Companies. The actual results of operations may differ significantly from the pro forma amounts reflected herein due to a variety of factors. In addition, the unaudited pro forma combined statement of operations do not reflect any future planned cost savings initiatives following the completion of the business combination.

The unaudited pro forma condensed combined financial information is prepared in accordance with SEC Regulation S-X Article 11, using the assumptions set forth in the notes to the unaudited pro forma condensed combined financial information.

2. Description of the Acquisition and Acquisition Related Financing

 

On May 8, 2019, the Company, through one of its subsidiaries, entered into a Purchase and Sale Agreement, as amended, with L. Perrigo Company and Perrigo Company plc to purchase all the outstanding capital stock of Sergeant’s Pet Care Products, Inc., including any assets related to Perrigo’s animal health business (the “Business”).  On July 7, 2019, the Company completed the acquisition of the Business.  Sergeant’s is now an indirect wholly-owned subsidiary of the Company. 

 

In connection with the closing of the acquisition of the Business, the Company and its domestic subsidiaries entered into an amended and restated term loan credit agreement on July 8, 2019 (the “A&R Term Loan Credit Agreement”) with a secured term loan facility of $220 million maturing on July 8, 2025, the proceeds of which were used to finance the existing term loan facility and consummate the acquisition of the Business.  

 

Additionally, the Company and its domestic subsidiaries amended their existing revolving credit agreement on July 8, 2019 (the “Credit Agreement Amendment”) to increase the size of the revolving facility to $110 million with an accordion feature allowing for an additional $125 million and extended maturity date of the revolving facility to July 8, 2024.  In

addition, the Credit Agreement Amendment reduces the interest rate on Eurodollar rate loans and modified certain financial covenants, including eliminating the maximum first lien and coverage ratio.  Collectively, the A&R Term Loan Credit Agreement and Credit Agreement Amendment are the acquisition related financings (“Acquisition Related Financing”). 

 

3. Accounting Policies and Reclassifications

 

The accounting policies used in the preparation of the unaudited pro forma condensed combined financial information are those set forth in the Company’s audited financial statements. Based on the preliminary review of accounting policies of Sergeant’s Business, the Company determined no significant adjustments are necessary to conform Sergeant’s historical financial statements to the accounting policies used by the Company in the preparation of the unaudited pro forma condensed combined financial information.  Upon completion of the review of the accounting policies, the Company may identify differences among the accounting policies of the companies that, when conformed, could have a material impact on the unaudited pro forma condensed combined financial information. 

 

Certain reclassifications and classifications adjustments have been made to the unaudited pro forma condensed combined financial information to conform Sergeant’s historical financial statements to the Company’s financial statement presentation.  Unless otherwise indicated, defined line items included in the footnotes have the meanings given to them in the historical financial statements of the Company. 

 

Reclassifications of the unaudited pro forma condensed combined balance sheet as of 3/30/2019.

 

 

 

 

 

 

 

 

 

 

 

Historical Sergeant's

 

 

Reclassification Amount

 

 

Historical As Adjusted

Accrued customer payables

$

3,602

 

$

(3,602)

(b)

$

 —

Accrued liabilities

 

2,758

 

 

2,121

(a)(b)

 

4,879

Current portion of operating leases

 

 —

 

 

1,481

(a)

 

1,481

 

a) Represents the reclassification of $1,481 of current operating lease liabilities from "Accrued Liabilities" to "Current portion of operating leases"

b) Represents the reclassification of $3,602 of accrued customer payables from "Accrued customer payables" to "Accrued Liabilities"

 

Reclassification of the unaudited pro forma condensed combined statement of income (loss) for:

 

Year ended December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

Historical Sergeant's

 

 

Reclassification Amount

 

 

Historical As Adjusted

Selling and Administrative Expenses

$

 —

 

$

35,993

aa

$

35,993

   Selling

 

16,379

 

 

(16,379)

aa

 

 —

   Administration

 

12,558

 

 

(12,558)

aa

 

 —

   Distribution

 

4,178

 

 

(4,178)

aa

 

 —

   Research and development

 

2,878

 

 

(2,878)

aa

 

 —

 

Quarter ended March 30, 2019

 

 

 

 

 

 

 

 

 

 

 

Historical Sergeant's

 

 

Reclassification Amount

 

 

Historical As Adjusted

Selling and Administrative Expenses

$

 —

 

$

8,684

aa

$

8,684

   Selling

 

4,018

 

 

(4,018)

aa

 

 —

   Administration

 

3,332

 

 

(3,332)

aa

 

 —

   Distribution

 

852

 

 

(852)

aa

 

 —

   Research and development

 

482

 

 

(482)

aa

 

 —

 

aa) Represents the reclassification Sergeant's historical selling, administration, distribution and research and development costs separately presented to "Selling and Administrative Expenses"

 

The unaudited pro forma condensed combined financial information may not reflect all reclassifications necessary to conform the Sergeant’s financial statement presentation to that of the Company.  Any additional reclassifications and classifications adjustments are not expected to have an effect on reported total assets, total liabilities, equity, or net income (loss).

 

4. Preliminary Purchase Price Allocation and Pro Forma Adjustments

 

The preliminary estimated purchase consideration and the preliminary allocation of the purchase price to the acquired identifiable assets and assumed liabilities are as follows: 

 

 

 

 

 

Tangible assets acquired:

 

 

 

Inventories

 

$

20,716

Property, plant and equipment

 

 

16,635

Other current assets

 

 

16,930

Other assets

 

 

10,831

Total tangible assets acquired

 

 

65,112

Intangible assets acquired

 

 

32,690

Liabilities assumed

 

 

24,982

Total preliminary assets acquired in excess of liabilities assumed

 

 

72,820

Goodwill

 

 

112,695

Estimated cash purchase consideration (1)

 

$

185,515

(1)

The consideration paid is subject to a working capital adjustment by which the consideration will be adjusted upward or downward depending on whether the final working capital amount exceeds or is less than a target amount. The working capital adjustment has not yet been finalized and the purchase consideration included in these pro forma financial statements does not reflect any adjustment for the working capital adjustment.

 

5. Adjustments to the Unaudited Pro Forma Condensed Combined Balance Sheet

 

(a)

Represents the net cash proceeds of $220 million from the Company’s amended and restated term loan facility and $25 million of additional borrowing under the Company’s amended revolving credit arrangement offset by the cash purchase consideration paid to complete the Sergeant’s acquisition and transaction costs incurred to complete to the complete the Acquisition Related Financing. 

 

 

 

 

 

Sources

 

 

 

Proceeds from Amended and Restated Term Loan Facility

 

$

220,000

Proceeds from Revolver

 

 

25,000

Total Proceeds from Financing

 

 

245,000

Uses

 

 

 

Estimated purchase consideration

 

 

185,515

Old Term Loan Payoff

 

 

74,438

Debt Issuance Costs(1)

 

 

5,512

Transaction Costs

 

 

4,562

Total uses

 

 

270,027

Net effect on cash

 

$

(25,027)

 

(1)

The Debt Issuance costs paid at closing are included on the combined balance sheet as follows:

 

 

 

 

 

Long-term debt, less current installments

 

$

4,630

Other non current assets

 

 

650

Accumulated deficit

 

 

232

Total debt issuance costs paid

 

$

5,512

 

 

(b)

Represents the adjustment necessary to state inventories acquired as of the pro forma acquisition date to their estimated fair value.  The valuation approaches used in the preliminary valuation exercise for inventory were the replacement cost approach and the comparative sales method approach. 

 

 

 

 

 

Fair value of acquired inventory

 

$

20,716

Elimination of Sergeant's historical inventory, net

 

 

(16,511)

Pro forma adjustment to inventory

 

$

4,205

 

(c)

Represents the adjustment necessary to eliminate prepaid expenses that will not benefit the acquirer PetIQ.

 

(d)

Reflects the adjustment to property plant and equipment related to the preliminary fair values for the acquired real and personal property.  The valuation approaches used were the sales comparison approach and cost approach. 

 

 

 

 

 

 

Fair value of acquired property, plant and equipment

 

$

16,635

Elimination of Sergeant's historical net book value of property, plant and equipment

 

 

(10,684)

Pro forma adjustment to property, plant and equipment

 

$

5,951

 

 

(e)

Represents the adjustment to record the preliminary fair value of the operating lease liabilities and corresponding right-of-use assets and the removal of Sergeant’s historical operating lease liabilities and right-of-use assets in accordance with ASC 842.  

 

 

 

 

 

Fair value of acquired right of use assets

 

$

10,820

Elimination of Sergeant's historical operating lease right of use assets

 

 

(11,161)

Pro forma adjustment to operating lease right of use assets

 

$

(341)

 

 

 

 

 

Fair value of acquired current portion of operating lease liabilities

 

$

1,875

Elimination of Sergeant's historical current portion of operating lease liability

 

 

(1,481)

Pro forma adjustment to current portion of operating lease liability

 

$

394

 

 

 

 

 

Fair value of acquired operating lease liabilities, less current installments

 

$

8,944

Elimination of Sergeant's historical operating lease liability, less current installments

 

 

(9,694)

Pro forma adjustment to operating lease liabilities, less current installments

 

$

(750)

 

(f)

Represents adjustment to reflect the preliminary fair value of Sergeant’s identifiable intangible and the removal of Sergeant’s historical net book value of intangible assets.  The related impact of these newly acquired intangibles on amortization expense have been reflected in the unaudited pro forma condensed statement of operations.  The net adjustments are calculated as follows:

 

 

 

 

 

Fair value of acquired intangibles

 

$

32,690

Elimination of Sergeant's historical net book value of intangibles

 

 

(36,922)

Pro forma adjustment to intangibles

 

$

(4,232)

 

The general categories of the acquired identified intangibles assets are expected to be the following: 

 

 

 

 

 

 

 

 

 

 

 

 

Useful Lives

Tradenames

 

$

22,020

 

5 - Indefinite

Customer Relationships

 

 

7,070

 

20

Developed technology and Know-How

 

 

2,960

 

8

In-Process Research & Development

 

 

640

 

Indefinite

Intangible assets

 

$

32,690

 

 

 

The preliminary fair values of the intangible assets were determined based on a combination of market, income and cost approaches.  Upon finalization of the fair values of the intangibles, the amount that will be allocated to the identifiable intangible assets, and the related amortization, may differ materially from this preliminary allocation. 

 

(g)

The adjustment to goodwill is comprised of the elimination of Sergeant’s historical goodwill and the preliminary purchase consideration in excess of the fair value of the net assets acquired.

 

 

 

 

 

Preliminary purchase consideration in excess of fair value of net assets acquired

 

$

112,695

Elimination of Sergeant's historical goodwill

 

 

(29,633)

Pro forma adjustment to goodwill

 

$

83,062

 

 

(h)

Represents the adjustment to record the proceeds, net of deferred financing costs, and record the corresponding debt related to the Acquisition Related Financing, described in Note 2, which proceeds were primarily used to fund the Sergeant’s acquisition and Term Loan refinancing.

 

 

 

 

 

 

Proceeds from financing

 

$

245,000

Repayments of debt assumed

 

 

(74,437)

Debt issuance costs related to Acquisition Related Financing

 

 

(4,630)

Pro forma adjustment for net adjustment to debt

 

$

165,933

 

 

 

 

 

Current portion of debt

 

$

1,450

Long-term debt

 

 

164,483

Total pro forma debt

 

$

165,933

 

(i)

Pro forma adjustment to record the elimination of Sergeant’s historical net parent investment.

 

(j)

To record the acquisition costs incurred by PetIQ to complete the transaction as well as the portion of debt issuance costs expensed in 5(a).  

 

6. Adjustments to the Unaudited Pro Forma Condensed Combined Statement of Operations

 

(a)

Reflects the elimination of Product sales and Cost of products Sold from Sergeant’s to PetIQ as part of the transition of a distribution agreement.

 

(b)

Represents adjustment to eliminate Sergeant’s historical depreciation and amortization and record depreciation and amortization based on the fair value of the acquired property, plant and equipment and identifiable intangible assets.  Depreciation of property plant and equipment is based on the estimated remaining useful lives of the assets and is calculated on a straight-line basis. The amortization of intangible assets is based on the periods over which the economic benefits of the intangible assets are expected to be realized. 

 

Cost of Products Sold

 

 

 

 

 

 

 

 

 

3 months ended

 

Year ended

 

 

March 30, 2019

 

December 31, 2018

Depreciation and Amortization

    

 

 

 

 

 

Depreciation and amortization expense of new fair value of assets

 

$

93

 

$

370

Elimination of Sergeant's historical depreciation and amortization

 

 

(1,456)

 

 

(21,156)

Pro forma adjustment to Costs of Products Sold

 

$

(1,363)

 

$

(20,786)

 

 

The fair value adjustment to the inventories was excluded from the pro forma condensed combined statements of operations as it was determined not to have a continuing effect.

 

 

 

 

 

     General and Administrative Expenses

 

 

 

 

 

 

 

 

    

3 months ended

 

Year ended

 

 

March 30, 2019

 

December 31, 2018

Depreciation and Amortization

 

 

 

 

 

 

Depreciation and amortization expense of new fair value of assets

 

$

640

 

$

2,612

Elimination of Sergeant's historical depreciation and amortization

 

 

(547)

 

 

(2,268)

Pro forma adjustment to General and Administrative Expenses

 

$

93

 

$

344

 

 

(c)

Reflects the elimination of transaction costs recorded in the historical financial statements of PetIQ of $576 for the three months ended March 31, 2019. 

 

(d)

Represents interest expense for additional borrowings of $220 million from the Company’s amended and restated term loan facility as well as the interest expense on the additional $25 million borrowed on the Company’s Revolver.  The Company obtained a variable interest rate of 2.1%, plus a margin of 4.5% on the amended and restated term loan and 5.3% on the Revolver using the base rate.  The effect of a 1/8 percent variance in the interest rates would change interest expense, net by approximately $213 and $53 for the year ended December 31, 2018 and the three months ended March 31, 2019, respectively.

 

(e)

Represents the pro forma adjustment for the income tax effect of the historical income of Perrigo’s animal health business as a result of its acquisition by PetIQ, as well as the income tax effect of the pro forma adjustments. With respect to the Unaudited Pro Forma Statement of Income (Loss), a blended federal and state statutory tax rate of 25% for the three months ended March 31, 2019 and the year ended December 31, 2018 has been assumed for the pro forma adjustments. The combined company is anticipated to not have a valuation allowance against the deferred tax asset and the recurring valuation allowance expense in the combined financial statements of Perrigo’s animal health business for June 30, 2019 and December 31, 2018, of $51 thousand and $16.9 million, respectively, has been removed from tax expense. We have not removed the tax impact of one-time items, including the 2018 impairment charge. 

 

Although not reflected in this unaudited pro forma condensed combined financial information, the effective tax rate of the combined company could be different than the Company’s historical effective tax rate (either higher or lower) depending on various factors, including post-acquisition activities.

(f)

The non-controlling interest income is calculated by first allocating an amount associated with the pro forma tax distributions to non-controlling interest holders, then allocating the remaining income attributable to PetIQ Holdings, LLC based on the pro forma ownership interest held by the non-controlling interest holders. In a loss situation the non-controlling interest holders will not receive income tax distributions based on provisions in the operating agreement.